Medication info
CantaBell A 16/5/20 mg Tablets

CantaBell A 16/5/20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletAtorvastatin Calcium›21.7mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Dark pink oval film-coated tablets
Packaging
30 tablets/PTP
Approval status
Active

MFDS item code 202200399 · Approved 2022.01.24 · Insurance code 643308900

Summary

Main use
Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This drug is administered as 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the candesartan cilexetil/amlodipine combination and atorvastatin. Patients taking candesartan cilexetil/amlodipine combination therapy and atorvastatin may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Candesartan cilexetil/amlodipine combination It is recommended that the dose of the individual components (candesartan cilexetil or amlodipine) be adjusted before administering the candesartan cilexetil/amlodipine combination; however, a direct switch to the combination may be considered if blood pressure is not controlled as follows. - 8/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or amlodipine 5 milligrams. - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or amlodipine 5 milligrams. - 16/10 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, amlodipine 10 milligrams, or candesartan cilexetil/amlodipine 16/5 milligrams. ○ Atorvastatin Patients taking atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). Atorvastatin is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of atorvastatin should be individualized according to the patient's characteristics, considering treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia Atorvastatin is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Because a starting dose of candesartan cilexetil of 4 milligrams once daily is recommended for patients with renal impairment, it is not advisable to use this drug as initial therapy. ○ Patients with hepatic impairment: Because a starting dose of candesartan cilexetil of 2 milligrams once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this drug as initial therapy.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • dyslipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary dysbetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used as a combination of candesartan cilexetil and amlodipine for patients with essential hypertension whose blood pressure is not adequately controlled. Additionally, atorvastatin helps reduce cholesterol and lipid levels in patients with dyslipidemia, thereby lowering the risk of cardiovascular diseases. It particularly reduces the risk of myocardial infarction and stroke in patients with risk factors for coronary artery disease or those with type 2 diabetes, and it decreases the risk of complications from cardiovascular diseases such as revascularization and angina. This drug also contributes to reducing the risk of hospitalization due to congestive heart failure. In summary, it helps maintain cardiovascular health by improving blood pressure and lipid management simultaneously.

How to take

Adult dose

This drug is administered as 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the candesartan cilexetil/amlodipine combination and atorvastatin. Patients taking candesartan cilexetil/amlodipine combination therapy and atorvastatin may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Candesartan cilexetil/amlodipine combination It is recommended that the dose of the individual components (candesartan cilexetil or amlodipine) be adjusted before administering the candesartan cilexetil/amlodipine combination; however, a direct switch to the combination may be considered if blood pressure is not controlled as follows. - 8/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or amlodipine 5 milligrams. - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or amlodipine 5 milligrams. - 16/10 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, amlodipine 10 milligrams, or candesartan cilexetil/amlodipine 16/5 milligrams. ○ Atorvastatin Patients taking atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). Atorvastatin is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of atorvastatin should be individualized according to the patient's characteristics, considering treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia Atorvastatin is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Because a starting dose of candesartan cilexetil of 4 milligrams once daily is recommended for patients with renal impairment, it is not advisable to use this drug as initial therapy. ○ Patients with hepatic impairment: Because a starting dose of candesartan cilexetil of 2 milligrams once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this drug as initial therapy.

Precautions

This drug may cause serious harm to the fetus or newborn when administered to pregnant women, so if pregnancy is confirmed, it should be discontinued immediately. If there are muscle-related diseases or severe muscle pain, or if muscle enzyme levels increase, the intake of this drug should be stopped, particularly in cases where there is a risk factor such as renal impairment, severe infection, or hypotension. This drug should not be used in patients with allergies to certain ingredients, severe liver disease, severe renal impairment, history of angioedema, or in children under 10 years of age. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, severe hypotension, valvular heart disease, and renal transplant recipients should be particularly cautious when using this drug. While taking this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly, and any symptoms of muscle pain or drug side effects should be reported to a healthcare professional immediately. This drug can interact with other antihypertensives, diuretics, specific antibiotics, antiviral agents, etc., so it is essential to inform healthcare professionals about any other medications being taken. Dizziness or drowsiness may occur while driving or operating machinery, so caution is necessary. It is advisable to avoid excessive intake of grapefruit juice while taking this drug, and if there are indications of liver dysfunction or muscle abnormalities, the administration should be discontinued immediately and medical consultation sought.

Side effects

  • Dizziness
  • headache
  • fainting
  • chest pain
  • edema
  • palpitations
  • urinary tract infection
  • colon polypectomy
  • low back pain
  • respiratory infection
Show 277 more
  • pharyngitis
  • rhinitis
  • asthenia
  • fever
  • sensory disturbance
  • indigestion
  • gastritis
  • tachycardia
  • palpitation
  • hyperkalemia
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • increased liver enzyme levels
  • hepatitis
  • jaundice
  • angioedema
  • urticaria
  • pruritus
  • rhabdomyolysis
  • arthralgia
  • myalgia
  • renal impairment
  • acute kidney failure
  • interstitial pneumonia
  • shock
  • loss of consciousness
  • increased blood pressure
  • gastrointestinal pain
  • orthostatic hypotension
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • altered taste sensation
  • erectile dysfunction
  • flushing
  • fatigue
  • edema
  • dizziness
  • drowsiness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • increase in weight
  • decrease
  • hypotension
  • vasculitis
  • hypertonia
  • sensory loss
  • sensory disturbance
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • indigestion
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • constipation
  • abdominal bloating
  • pharyngeal laryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • sensory disturbance
  • amnesia
  • peripheral neuropathy
  • muscle cramps
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • tendon disorders
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • anaphylaxis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • hearing loss
  • vascular neurogenic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal laryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • myopathy
  • myositis
  • rhabdomyolysis
  • anemia
  • decreased testosterone
  • increase in cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • gynecomastia
  • increased potassium
  • increased BUN
  • cerebral infarction
  • palpitation
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • post-prandial dysphagia
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • epistaxis
  • sensory disturbance
  • photodermatitis
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • hypertonia
  • muscle cramps
  • muscle fatigue
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • synovitis
  • myasthenia
  • tendon shortening
  • increased CK
  • elevated serum myoglobin
  • pruritus
  • rash
  • alopecia
  • contact dermatitis
  • skin dryness
  • sweating
  • acne
  • urticaria
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • chromaturia
  • hypoglycemia
  • hyperglycemia
  • loss of appetite
  • increased appetite
  • lethargy
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck rigidity
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • postural sense changes
  • loss of taste
  • ageusia
  • thrombocytopenia
  • leukopenia
  • anemia
  • hemorrhagic stroke

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to store it at room temperature, specifically between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Dark pink oval film-coated tablets

Package unit

30 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.